中文名称 |
英文名称 |
CAS号 |
化学式 |
结构式图片 |
N'-(5,7-二氯-2-氧代-2H-吲哚-3-基)-2-(4-甲基-1-哌嗪基)乙酰肼 |
1-Piperazineacetic acid, 4-methyl-, (5,7-dichloro-2-oxo-3-indolinylidene)hydrazide, (Z)- |
86873-26-9 |
C15H17Cl2N5O2 |
|
N'-(3,4-二氯苯基)-4-(2-甲氧基苯基)哌嗪-1-甲脒二盐酸盐 |
N'-(3,4-dichlorophenyl)-4-(2-methoxyphenyl)piperazine-1-carboximidamide;hydron;dichloride |
—— |
C18H22Cl4N4O |
|
N'-(2-氧代-2H-吲哚-3-基)-2-(1-哌嗪基)乙酰肼二盐酸盐 |
1-Piperazineacetic acid, (2-oxo-3-indolinylidene)hydrazide, dihydrochloride, sesquihydrate, (Z)- |
86873-20-3 |
C14H19Cl2N5O2 |
|
MK 212盐酸盐 |
6-chloro-2-(1-piperazinyl)pyrazine |
64022-27-1 |
C8H11ClN4 |
|
LP-12盐酸盐 |
LP 12 hydrochloride |
1185136-22-4 |
C32H40ClN3O |
|
LEE011琥珀酸盐 |
ribociclib succinate |
1374639-75-4 |
C4H6O4*C23H30N8O |
|
LB-100抑制剂 |
LB-100 |
1026680-07-8 |
C13H20N2O4 |
|
L-苯丙氨酸,2,5-二甲氧基- |
3-(Pyridin-3-YL)-3,8-diazabicyclo[3.2.1]octane |
286944-38-5 |
C11H15N3 |
|
L-778123二盐酸盐 |
L-778123 Dihydrochloride |
183499-56-1 |
C22H22Cl3N5O |
|
L-750667三盐酸盐 |
L-750,667 trihydrochloride |
1021868-80-3 |
C18H22Cl3IN4 |
|
KRasG12C抑制剂4 |
KRas G12C inhibitor 4 |
2206736-07-2 |
C33H38ClN7O2 |
|
I型P21激活激酶(PAK)抑制剂(FRAX597) |
FRAX597 |
1286739-19-2 |
C29H28ClN7OS |
|
INTEPIRDINE中间体 |
tert-butyl 4-[3-(phenylsulfonyl)quinolin-8-yl]piperazine-1-carboxylate |
607743-10-2 |
C24H27N3O4S |
|
HSD抑制剂23 |
N-[(E)-5-hydroxy-2-adamantyl]-2-methyl-2-{4-[5-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl}propanamide |
868604-75-5 |
C24H33F3N4O2 |
|
HOECHST33258类似物5,BR |
2'-(naphth-2-yl)-5-(4-methylpiperazinyl)-2,5'-bi-1H-benzimidazole |
23491-55-6 |
C29H26N6 |
|
FGFR抑制剂(NVP-BGJ398) |
BGJ398 |
872511-34-7 |
C26H31Cl2N7O3 |
|
EZH2甲基转移酶抑制剂(GSK126) |
GSK-126 |
1346574-57-9 |
C31H38N6O2 |
|
DL-乳酸伏硫西汀 |
1-[2-(2,4-dimethyl-phenylsulfanyl)phenyl]piperazine DL-lactate |
1253056-29-9 |
C3H6O3*C18H22N2S |
|
CO-1686氢溴酸盐 |
Rociletinib hydrobromide |
1446700-26-0 |
2BrH*C27H28F3N7O3 |
|
CO-1686中间体三 |
1-(4-(4-amino-3-methoxyphenyl)piperazin-1-yl)ethanone |
1021426-42-5 |
C13H19N3O2 |
|
CERDULATINIB盐酸盐 |
cerdulatinib hydrochloride |
1369761-01-2 |
C20H27N7O3S*ClH |
|
CCT 129202; 2-[4-[6-氯-2-(4-二甲基氨基苯基)-3H-咪唑并[4,5-b]吡啶-7-基]哌嗪-1-基]-N-(噻唑-2-基)乙酰胺 |
CCT 129202 |
942947-93-5 |
C23H25ClN8OS |
|
Bitopertin中间体 |
1-(3-fluoro-5-(trifluoromethyl)pyridin-2-yl)piperazine |
845616-81-1 |
C10H11F4N3 |
|
BOC-2-甲基哌嗪甲酰氯 |
tert-butyl (R)-4-(chlorocarbonyl)-3-methylpiperazine-1-carboxylate |
438050-54-5 |
C11H19ClN2O3 |
|
BMS 554417; 4-[2-[4-[[(2S)-2-(3-氯苯基)-2-羟基乙基]氨基]-1,2-二氢-2-氧代-3-吡啶基]-7-甲基-1H-苯并咪唑-5-基]-1-哌嗪丙腈 |
BMS-554417 |
468741-42-6 |
C28H30ClN7O2 |
|
氨苄西林杂质G |
(3R,6R)-3,6-bis(phenyl)piperazine-2,5-dione |
31485-02-6 |
C16H14N2O2 |
|
ABT-199中间体 |
4-(2-bromo-5,5-dimethyl-cyclohex-1-enylmethyl)-piperazine-1-carboxylic acid tert-butyl ester |
1229247-71-5 |
C18H31BrN2O2 |
|
9H-嘌呤,8-甲氧基-9-甲基-6-(1-哌嗪基)- |
8-Methoxy-9-methyl-6-(1-piperazinyl)purine |
121370-86-3 |
C11H16N6O |
|
9-苯基-8-(4-苯基哌嗪-1-基)双环[3.3.1]壬烷-9-醇 |
2-(4-Phenyl-1-piperazinyl)-9-phenylbicyclo<3.3.1>nonan-9-ol |
30297-79-1 |
C25H32N2O |
|
9-甲基-3,9-二氮杂双环[3.3.1]壬烷-7-醇 |
9-Methyl-3,9-diazabicyclo[3.3.1]nonan-6-OL |
3181-47-3 |
C8H16N2O |
|
9-甲基-2-[4-(2-嘧啶基)-1-哌嗪基]-9H-嘌呤 |
9-methyl-2-(4-pyrimidin-2-yl-piperazin-1-yl)-9<i>H</i>-purine |
24926-44-1 |
C14H16N8 |
|
9-(4-甲基哌嗪-1-基)-4-(2-甲基丙基)-7-吡咯烷-1-基-4,8,10-三氮杂双环[4.4.0]癸-7,9,11-三烯 |
6-Isobutyl-2-(4-methyl-piperazino)-4-pyrrolidino-5,6,7,8-tetrahydro-pyrido<4,3-d>pyrimidin |
7128-36-1 |
C20H34N6 |
|
9,9-二甲基-3-[3-(1-甲基哌啶正离子-1-基)丙酰]-3-氮杂-9-氮鎓杂二环[3.3.1]壬烷二碘化 |
3-Aza-9-azoniabicyclo(3.3.1)nonane, 9,9-dimethyl-3-(3-(1-methylpiperidinio)propionyl)-, diiodide |
102585-73-9 |
C18H35I2N3O |
|
9,9-二甲基-3-[3-(1-甲基哌啶正离子-1-基)丙基]-3-氮杂-9-氮鎓杂二环[3.3.1]壬烷二碘化 |
3-Aza-9-azoniabicyclo(3.3.1)nonane, 9,9-dimethyl-3-(3-(1-methylpiperidinio)propyl)-, diiodide |
102585-74-0 |
C18H37I2N3 |
|
8-(5-氯-2-(4-甲基哌嗪-1-基)异烟酰胺基)-1-(4-氟苯基)-4,5,二氢-1H-苯并[g]吲唑-3-甲酰胺 |
PHA-408 |
503555-55-3 |
C29H27ClFN7O2 |
|
8-苯基-2-(1-哌嗪基)-4H-1-苯并吡喃-4-酮 |
2-Piperazinyl-8-phenyl-4H-1-benzopyran-4-one |
154447-38-8 |
C19H18N2O2 |
|
8-苄基-3,8-二氮杂双环[3.2.1]辛烷-3-羧酸叔丁酯 |
tert-butyl 8-benzyl-3,8-diazabicyclo[3.2.1]octane-3-carboxylate |
201162-52-9 |
C18H26N2O2 |
|
8-甲氧基-2-哌嗪-1-基喹啉 |
8-Methoxyquipazine |
104090-79-1 |
C14H17N3O |
|
8-甲基-1,8-二氮杂双环[3.3.1]壬烷 |
1,2-Diazabicyclo(3.3.1)nonane, 2-methyl- |
70873-22-2 |
C8H16N2 |
|
8-环戊基-7,8-二氢-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-7-氧代-吡啶并[2,3-d]嘧啶-6-甲腈 |
8-cyclopentyl-2-[4-(4-methyl-piperazin-1-yl)-phenylamino]-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidine-6-carbonitrile |
1357470-29-1 |
C24H27N7O |
|
8-溴-4-(4-甲基哌嗪-1-基)喹唑啉-2-胺 |
8-bromo-4-(4-methylpiperazin-1-yl)quinazolin-2-amine |
1258630-98-6 |
C13H16BrN5 |
|
8-溴-2-(哌嗪-1-基)喹啉 |
8-bromo-2-piperazin-1-yl-quinoline |
348133-70-0 |
C13H14BrN3 |
|
8-氯-6-(2-氯苯基)-1-(4-(2-甲氧基乙基)-1-哌嗪基)-4H-(1,2,4)三唑并(4,3-a)(1,4)苯并二氮杂卓(E)-2-丁烯二酸酯(1:2) |
4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-6-(2-chlorophenyl)-1-(4-(2-methoxyethyl)-1-piperazinyl)-, (E)-2-butenedioate (1:2) |
88701-70-6 |
C31H32Cl2N6O9 |
|
8-氯-1-甲基-5-(4-甲基哌嗪-1-基)-6-苯基-[1,2,4]三唑并[4,3-a][1,5]苯并二氮杂卓 |
RL 218 |
153901-56-5 |
C22H23ClN6 |
|
8-氨基-1-[(5-氯-2-羟基苯基)偶氮]-2-萘酚 |
1-(N-Oxido-4-pyridyl)piperazin |
337956-37-3 |
C9H13N3O |
|
8-氟辛酸 |
(E)-but-2-enedioic acid;[1-(1,3-dioxo-3a,4,7,7a-tetrahydroisoindol-2-yl)-3-(4-pyridin-2-ylpiperazin-1-yl)propan-2-yl] hexanoate |
84916-38-1 |
C34H44N4O12 |
|
8-氟-4-(1-哌嗪基)-2-(三氟甲基)喹啉 |
1-(8-fluoro-2-trifluoromethyl-4-quinolyl)piperazine |
401567-86-0 |
C14H13F4N3 |
|
8-异喹啉甲胺双盐酸盐 |
7-piperazine-1-yl-thieno[2,3-c]pyridine hydrochloride |
850734-85-9 |
C11H13N3S*ClH |
|
8-哌嗪-1-萘-2-醇 |
8-(piperazin-1-yl)naphthalen-2-ol |
189350-02-5 |
C14H16N2O |
|
8-哌嗪-1-基咪唑并[1,2-a]吡嗪 |
8-(1-piperazinyl)imidazo<1,2-a>pyrazine |
76537-53-6 |
C10H13N5 |
|